While FOXA1 has been shown to interact with TET1 in the LNCaP (lymph node carcinoma of the prostate) cell line [23], no interaction has been reported in breast cancer cell lines with neither TET1 nor TET2, to the best of our knowledge. Here, TET2 is linked to breast cancer.